Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women

NCT00651846 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Yasmin (DRSP 3mg/EE 0.03 mg)
DRUG: Microgynon (LNG 0.15 mg/EE 0.03 mg)

Sponsor

Bayer